Table 1.
A comparison of baseline patient characteristics with solitary plasmacytoma (SP) from Brazil and the UK.
Table 2.
Location of solitary plasmacytoma (SP).
Fig 1.
(A) Cumulative Incidence of Multiple Myeloma (MM) by Solitary plasmacytoma type: EMD = extramedullary disease/plasmacytoma (B): The effect of plasmacytoma type on progression free survival (PFS): SBP = solitary bony plasmacytoma, EMD = extramedullar plasmacytoma.
Fig 2.
How radiotherapy dose (radical >40Gy, or palliative <40Gy) affects progression free survival (PFS).
Table 3.
The number of patients receiving surgical resection based on solitary plasmacytoma location.
Fig 3.
(A) SBP treatment pathways (B) EMP treatment pathways.
Table 4.
A comparison table of papers from the literature exploring outcomes in solitary plasmacytoma.